# Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage

> **NCT07144956** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Centre Hospitalier St Anne** · enrollment: 630 (estimated)

## Conditions studied

- Aneurysmal Subarachnoid Hemorrhage

## Interventions

- **BIOLOGICAL:** Cilostazol (Pletal®) 100 mg Tablets
- **DRUG:** Placebo
- **DRUG:** Nimodipine group

## Key facts

- **NCT ID:** NCT07144956
- **Lead sponsor:** Centre Hospitalier St Anne
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2029-12-14
- **Final completion:** 2029-12-14
- **Target enrollment:** 630 (ESTIMATED)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07144956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07144956, "Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07144956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*